Patents
Literature
36 results about "Gene subset" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Genetic transcripts as signatures of TEAD-activated cancers
PendingJP2026511729AMicrobiological testing/measurementForeign genetic material cellsNDUFS5Diagnostic methods
The present invention relates to a set of gene transcripts (A) isolated from a set of genes consisting of gene subset (1) consisting of ADM, AXL, BIRC5, CDV3, CRIM1, CTGF, CYR61, FSTL1, GADD45A, KRT8, LMNB2, MATN2, PKP4, RND3, RPS24, SEC14L1, SGK1, SLC25A3, SLC3A2, TNFRSF12A, TPM1, TPX2, and TUBB6; and an isolated set of genes (B) consisting of at least one gene transcript from gene subset (2) consisting of CTSB, FTH1, SQSTM1, TCF25, and UBC, or from a set of genes consisting of DLC1, AKAP2, CANX, SAFB2, EIF4H, NDUFS5, SEPT9, and EIF4A1, as well as their use in a diagnostic method for TEAD-activated cancer.
Owner:SANOFI SA(FR)
Gene Transcripts as Signatures for Tead-Active Cancer
The invention relates to an isolated set of gene transcripts (A) from a set of genes consisting of a subset of genes (1) consisting of ADM, AXL, BIRC5, CDV3, CRIM1, CTGF, CYR61, FSTL1, GADD45A, KRT8, LMNB2, MATN2, PKP4, RND3, RPS24, SEC14L1, SGK1, SLC25A3, SLC3A2, TNFRSF12A, TPM1, TPX2, TUBB6 and of a subset of genes (2) consisting of CTSB, FTH1, SQSTM1, TCF25, UBC, or an isolated set of genes (B) consisting of at least one gene transcript from a set of genes consisting of DLC1, AKAP2, CANX, SAFB2, EIF4H, NDUFS5, SEPT9, and EIF4A1, and their use in diagnostic methods for TEAD-active cancer.
Owner:SANOFI SA(FR)